Since CD44 is a cell surface adhesion receptor, we evaluated the potential role of the MSN-CD44 regulatory axis in the observed tumor-suppressing capabilities and expression of K-Ras in PDAC cells. The gene discussed is KRAS; the disease is neoplasm.